McDermott Will & Emery
Subscribe to McDermott Will & Emery's Posts5 Questions with a Health Lawyer: Steven J. Schnelle
By McDermott Will & Emery on Sep 17, 2020
Posted In Uncategorized
Steven J. Schnelle Practice Focus Area: Healthcare Office: New York Years at Firm: 2.5 years What is your favorite part about practicing healthcare law at McDermott? Without a doubt, the people! Every day I have the pleasure and honor of working with brilliant and unique colleagues that recognize and appreciate one another’s contributions to our...
Continue Reading
Public Hospital M&A: Know Your Stakeholders
By McDermott Will & Emery on Aug 24, 2020
Posted In Health M&A, Hospitals & Health Systems, Tax-Exempt
Hospital transactional activity has soared over the last decade, and many public hospitals are evaluating M&A opportunities against the backdrop of the Coronavirus (COVID-19) pandemic. In our previous post on public hospital M&A, we discussed financial pressures on public hospitals, trends driving M&A, and external factors shaping public hospitals’ choices of M&A partners and formats....
Continue Reading
5 Questions with a Health Policy Specialist: Rodney L. Whitlock of McDermott+Consulting
By McDermott Will & Emery on Aug 20, 2020
Posted In Uncategorized
Rodney L. Whitlock, Ph.D Vice President, McDermott+Consulting Focus Area: Healthcare Policy Years at M+: 1.5 years What is your favorite part about your health policy work at McDermott+Consulting? Healthcare policy, politics and process is complicated. It is a constant challenge to discern and anticipate the future of healthcare policy for clients. It is the constant...
Continue Reading
European Healthcare Innovation & Investment in a Post-Pandemic World
By McDermott Will & Emery on Jul 6, 2020
Posted In Digital Health, Health M&A, Health Private Equity, Hospitals & Health Systems, International Health
As part of McDermott’s HPE Europe 2020: Where Do the Opportunities Exist for Investment in the Healthcare Sector? webinar, McDermott London Managing Partner Hamid Yunis moderated a panel of industry experts including; Dr. Michelle Tempest of Candesic, Dr. Joanne Hackett of IZY Capital, Dr. Charles Niehaus and Professor Karol Sikora of Rutherford Cancer Centres, who...
Continue Reading
Unpacking Differences in Public and Private Hospital M&A
By McDermott Will & Emery on Jun 15, 2020
Posted In Health M&A, Hospitals & Health Systems, Tax-Exempt
Across the public hospital sector, M&A activity has increased significantly over the past decade. Given the current COVID-19 landscape, many are taking a hard look at their operations to garner a better understanding of what needs to be done to be regain level footing during a tough financial time, while also focusing on a need...
Continue Reading
More Than a Decade at the Top; McDermott Earns 11th Chambers USA Band 1 Healthcare Practice National Ranking
By McDermott Will & Emery on May 6, 2020
Posted In Uncategorized
We are pleased to announce that our Healthcare Group received a national Band 1 ranking for the eleventh year in a row in the 2020 edition of Chambers USA. After more than a decade at the top, we are once again the only one to rank Band 1 nationally. The Health team also earned Band...
Continue Reading
Top Takeaways: Critical Business Considerations for Life Sciences and Medical Device Companies During COVID-19
By McDermott Will & Emery on May 5, 2020
Posted In FDA, Life Sciences
Life sciences and medical device companies are dealing with an unprecedented crisis. The industry is not only managing the impact of Coronavirus (COVID-19), they are also a solution provider. Companies are rapidly adapting products, services, facilities and distribution channels to aid in the pandemic response. Simultaneously, they must maintain shareholder value, navigate highly complex regulatory...
Continue Reading
Coronavirus Resource Center | Preparedness Planning for Businesses
By McDermott Will & Emery on Mar 5, 2020
Posted In Digital Health, Hospitals & Health Systems, International Health
In our global economy, Coronavirus (COVID-19) raises serious concerns for employers in all industries. Workers may be on the front lines caring for patients and developing vaccines, travelling for business, or in close contact with individuals who travel or may have been affected. At this time, there is no vaccine or medication approved to prevent...
Continue Reading
Five Questions with a Health Lawyer: Nicholas Alarif
By McDermott Will & Emery on Feb 28, 2020
Posted In Fraud & Abuse
Nicholas Alarif Office: Washington, DC Years at Firm: 3 What is your favorite part about practicing healthcare law at McDermott? I hate to sound like a broken record, but the best part about practicing at McDermott is the innovative and collaborative culture. I have found that McDermott fosters a team-based approach to solving client issues....
Continue Reading
Five Questions with a Health Lawyer: Matt Perreault
By McDermott Will & Emery on Feb 14, 2020
Posted In Hospitals & Health Systems, Uncategorized
Matt Perreault Office: Boston Years at Firm: 2 What is your favorite part about practicing health care law at McDermott? As so many of my colleagues have expressed throughout this series, my favorite part of practicing healthcare law at McDermott is being a member of a collaborative and collegial team that is advising our diverse...
Continue Reading
